Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

The new compound may be a safer alternative to finasteride for prostate protection.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Combination therapy is more effective for prostate volumes over 60 ml.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

New compounds show promise as nonsteroidal treatments for hair loss.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The market for these drugs is expected to grow.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Blocking testosterone action may improve breathing during NREM sleep in healthy men.

Certain drugs that block specific enzymes can help treat prostate diseases.